30 related articles for article (PubMed ID: 31815680)
1. The PAPSS1 gene is a modulator of response to cisplatin by regulating estrogen receptor alpha signaling activity in ovarian cancer cells.
Sun L; Ji WX; Li Y; Li ZL; Duan CC; Xia BR; Xiao L
J Ovarian Res; 2023 Sep; 16(1):187. PubMed ID: 37684671
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer.
Liu X; Bao X; Hu M; Chang H; Jiao M; Cheng J; Xie L; Huang Q; Li F; Li CY
Nature; 2020 Dec; 588(7839):693-698. PubMed ID: 33177715
[TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein receptor (LDLR) regulates NLRP3-mediated neuronal pyroptosis following cerebral ischemia/reperfusion injury.
Sun R; Peng M; Xu P; Huang F; Xie Y; Li J; Hong Y; Guo H; Liu Q; Zhu W
J Neuroinflammation; 2020 Nov; 17(1):330. PubMed ID: 33153475
[TBL] [Abstract][Full Text] [Related]
4. Involvement of FAM83 Family Proteins in the Development of Solid Tumors: An Update Review.
Jiang Y; Yu J; Zhu T; Bu J; Hu Y; Liu Y; Zhu X; Gu X
J Cancer; 2023; 14(10):1888-1903. PubMed ID: 37476189
[TBL] [Abstract][Full Text] [Related]
5. A Novel 3D Culture Scaffold to Shorten Development Time for Multicellular Tumor Spheroids.
Yang CR; Liang CT; Tsai SC; Wu YC; Liu CW; Yang HH; Tu TY; Lee YC; Hsiao KY; Chang WC; Ma WL
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430445
[TBL] [Abstract][Full Text] [Related]
6. Linking Late Endosomal Cholesterol with Cancer Progression and Anticancer Drug Resistance.
Nguyen MKL; Jose J; Wahba M; Bernaus-Esqué M; Hoy AJ; Enrich C; Rentero C; Grewal T
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806209
[TBL] [Abstract][Full Text] [Related]
7. The Role of Lipid Metabolism in Gastric Cancer.
Cui MY; Yi X; Zhu DX; Wu J
Front Oncol; 2022; 12():916661. PubMed ID: 35785165
[TBL] [Abstract][Full Text] [Related]
8. Targeting lipid metabolism in the treatment of ovarian cancer.
Chaudhry S; Thomas SN; Simmons GE
Oncotarget; 2022; 13():768-783. PubMed ID: 35634242
[TBL] [Abstract][Full Text] [Related]
9. Ursolic acid silences CYP19A1/aromatase to suppress gastric cancer growth.
Ma WL; Chang N; Yu Y; Su YT; Chen GY; Cheng WC; Wu YC; Li CC; Chang WC; Yang JC
Cancer Med; 2022 Jul; 11(14):2824-2835. PubMed ID: 35545835
[TBL] [Abstract][Full Text] [Related]
10. Low Density Lipoprotein Receptor (LDLR) and 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase (HMGCR) Expression are Associated with Platinum-Resistance and Prognosis in Ovarian Carcinoma Patients.
Huang X; Wei X; Qiao S; Zhang X; Li R; Hu S; Mao H; Liu P
Cancer Manag Res; 2021; 13():9015-9024. PubMed ID: 34908877
[TBL] [Abstract][Full Text] [Related]
11. Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets.
He J; Siu MKY; Ngan HYS; Chan KKL
Front Oncol; 2021; 11():738177. PubMed ID: 34820325
[TBL] [Abstract][Full Text] [Related]
12. Metronomic Celecoxib Therapy in Clinically Available Dosage Ablates Hepatocellular Carcinoma via Suppressing Cell Invasion, Growth, and Stemness in Pre-Clinical Models.
Yeh CC; Liao PY; Pandey S; Yung SY; Lai HC; Jeng LB; Chang WC; Ma WL
Front Oncol; 2020; 10():572861. PubMed ID: 33194674
[TBL] [Abstract][Full Text] [Related]
13. LDLR-mediated lipidome-transcriptome reprogramming in cisplatin insensitivity.
Chang WC; Wang HC; Cheng WC; Yang JC; Chung WM; Ho YP; Chen L; Hung YC; Ma WL
Endocr Relat Cancer; 2020 Feb; 27(2):81-95. PubMed ID: 31815680
[TBL] [Abstract][Full Text] [Related]
14. Targeting lipid droplet lysophosphatidylcholine for cisplatin chemotherapy.
Chen L; Ma WL; Cheng WC; Yang JC; Wang HC; Su YT; Ahmad A; Hung YC; Chang WC
J Cell Mol Med; 2020 Jul; 24(13):7187-7200. PubMed ID: 32543783
[TBL] [Abstract][Full Text] [Related]
15. MiR-363 inhibits cisplatin chemoresistance of epithelial ovarian cancer by regulating snail-induced epithelial-mesenchymal transition.
Cao L; Wan Q; Li F; Tang CE
BMB Rep; 2018 Sep; 51(9):456-461. PubMed ID: 30037365
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of RIF1 Enhances Sensitivity to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC) by Regulating Nucleotide Excision Repair (NER) Pathway.
Liu YB; Mei Y; Tian ZW; Long J; Luo CH; Zhou HH
Cell Physiol Biochem; 2018; 46(5):1971-1984. PubMed ID: 29719287
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of mismatch repair gene hMSH2 associates with platinum-resistant disease in epithelial ovarian cancer.
Tian H; Yan L; Xiao-Fei L; Hai-Yan S; Juan C; Shan K
Clin Epigenetics; 2019 Oct; 11(1):153. PubMed ID: 31666131
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
